---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-117878"
form_type: "8-K"
ticker: "KALV"
cik: "0001348911"
company_name: "KalVista Pharmaceuticals, Inc."
filed_at: "2025-05-12T23:59:59+00:00"
generated_at: "2026-05-21T23:15:31.713977+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# KalVista COO Jebediah T. Ledell resigns effective May 12, 2025

## Summary
- COO Jebediah T. Ledell resigned effective immediately on May 12, 2025.
- No replacement or interim COO has been named by the company.
- Resignation filed under Item 5.02; no reason for departure provided.

## SEC filing metadata
- accession: 0001193125-25-117878
- form_type: 8-K
- ticker: KALV
- cik: 0001348911
- company_name: KalVista Pharmaceuticals, Inc.
- filed_at: 2025-05-12T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348911/000119312525117878/0001193125-25-117878-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348911/000119312525117878/d866380d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-117878
- JSON: https://secwatch.observer/filing/0001193125-25-117878.json
- Plain text: https://secwatch.observer/filing/0001193125-25-117878.txt

## Key facts
- Executive change
  Jebediah T. Ledell resigned as Chief Operating Officer at KalVista Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Chief Operating Officer
  source text: On May 12, 2025, Jebediah T. Ledell notified KalVista Pharmaceuticals, Inc. (the “Company”) of his decision to resign from his position as Chief Operating Officer of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1348911/000119312525117878/0001193125-25-117878-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.